Abstract
The regulation of c-myc protein, product of c-myc/genes, was studied in four glioma cell lines by Northern blot, pulse-chase dot blot, immunoblot and immunoprecipitation analyses. Northern blot analysis revealed no overexpression of c-myc transcript, and pulse-chase dot blot analysis showed normal turnover rate of c-myc transcript, suggestive of no evidence of aberrant regulation of c-myc at post-transcriptional level. The synthesis levels of c-myc protein were shown by immunoprecipitation and closely associated with the c-myc transcript levels demonstrated by Northern blot, suggestive of no evidence of aberrant translational control of c-myc, whereas they were dissociated from the accumulation levels of c-myc protein shown by immunoblot, suggestive of an evidence of aberrant regulation of c-myc at post-translational level. The mean (±standard deviation) half-lives of c-myc protein in four glioma cell lines were calculated from the pulse-chase immunoprecipitation analysis, and being 98±8 to 143±11 min, were about four-to sixfold longer than normal. In surgical specimens, the immunostain of c-myc protein was not found in normal astrocytes but localized heterogeneously in nuclei of reactive astrocytes and glioma cells, and increased in stained cell number in proportion to malignancy. Although this study was limited to four glioma cell lines, it suggests that the c-myc protein in glioma cells may be accumulated due to its prolonged half-life contributing to an uncontrolled proliferation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chomosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707–1711
Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene amplification in malignant human gliomas: clinical and histopathological aspects. J Neuropathol Exp Neurol 47:191–205
Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217
Blanchard JM, Piechaczyk M, Dani C, Chambard JC, Franchi A, Pouyssegur J, Jeanteur P (1985) c-myc gene is transcribed at high rate in Go-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317:443–445
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Brewer G, Rose J (1989) Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol Cell Biol 9:1996–2006
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361–384
Cory S (1986) Activation of cellular oncogenes in hematopoietic cells by chromosome translocation. Adv Cancer Res 47:189–234
Dani C, Blanchard JM, Piechaczyk M, El-Sabouty S, Marty L, Jeanteur P (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 81:7046–7050
Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE, Campisi J (1986) Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact J Biol Chem 261:9161–9166
Engelhard HH III, Butler AB IV, Bauer KD (1989) Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue. J Neurosurg 71:224–232
Fujimoto M, Sheridan PJ, Sharp ZD, Weaker FJ, Kagan-Hallet KS, Story JL (1989) Proto-oncogene analyses in brain tumors. J Neurosurg 70:910–915
Halazonetis TD, Kandil AN (1991) Determination of the c-MYC DNA-binding site. Proc Natl Acad Sci USA 88:6162–6166
Hann SR, Eisenman RN (1984) Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 4:2486–2497
Hann SR, Thompson CB, Eisenman RN (1985) C-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366–369
Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN (1988) A non-AUG translational initiation in c-myc exon 1 generates in N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185–195
Holte H, Stokke T, Smeland E, Watt R, Blomhoff HK, Kaalhus O, Ohlsson R (1989) Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas. Int J Cancer 43:164–170
Hoshino T, Prados M, Wilson CB, Cho KG, Lee K-S, Davis RL (1989) Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg 71:335–341
Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85:316–322
Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610
Kleihues P, Burger PC, Scheithauer BW (1992) Histological typing of tumours of the central nervous system, 2nd edn. Springer Verlag, Berlin Heidelberg New York Tokyo
Kunishio K, Mishima N, Matsuhisa T, Tsuno K, Matsumi N, Satoh T, Matsumoto K, Furuta T, Nishimoto A, Shiraishi T (1990) Immunohistochemical demonstration of DNA polymerase α in human brain tumors. J Neurosurg 72:268–272
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Littlewood TD, Evan GI (1990) The role of myc oncogenes in cell growth and differentiation. Adv Dent Res 4:69–79
Louis DN, Meehan SM, Ferrante RJ, Hedley-Whyte ET (1992) Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 51:150–157
Lüscher B, Eisenman RN (1990) New light on Myc and Myb. I. Myc. Genes Dev 4:2025–2035
Marcu KB (1987) Regulation of expression of the c-myc protooncogene. Bioessays 6:28–32
Miyamoto C, Chizzonite R, Crowl R, Rupprecht K, Kramer R, Shaber M, Kumar G, Poonian M, Ju G (1985) Molecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Sacchromyces cervisiae: comparison of the protein products. Proc Natl Acad Sci USA 82:7232–7236
Moore JP, Hancock DC, Littlewood TD, Evan GI (1987) A sensitive and quantitative enyzme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res 2:65–80
Orian JM, Vasilopoulos K, Yoshida S, Kaye AH, Chow CW, Gonzales MF (1992) Overexpression of multiple oncogenes related to histological grade of astrocytic glioma. Br J Cancer 66:106–112
Persson H, Henninghausen L, Taub R, DeGrado W, Leder P (1984) Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science 225:687–693
Plate KH, Rüschoff J, Behke J, Mennel HD (1990) Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki67-immunoreactivity. Acta Neurochir (Wien) 104:103–109
Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH (1985) Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4:2009–2015
Ramsay G, Evan GI, Bishop JM (1984) The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci USA 81:7742–7746
Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541–544
Shindo H, Tani E, Kochi N, Kaba K, Matsumoto T, Miyaji K, Yamamoto Y, Furuyama J (1991) Interspecies comparison of c-myc gene in human and rat glioma cell lines. Acta Neuropathol 81:382–387
Spector DL, Watt RA, Sullivan NF (1987) The v- and c-myc oncogene proteins co-localize in situ with small nuclear ribonucleoprotein particles. Oncogene 1:5–12
Swartwout SG, Kinniburgh AJ (1989) c-myc RNA degradation in growing and differentiating cells: possible alternate pathways. Mol Cell Biol 9:288–295
Swartwout SG, Preisler H, Guan WD, Kinniburgh AJ (1987) Relatively stable population of c-myc RNA that lacks long poly (A). Mol Cell Biol 7:2052–2058
Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76:792–798
Thompson CB, Challoner PB, Neiman PE, Groudine M (1985) Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314:363–366
Trent J, Meltzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Feinberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sci USA 83:470–473
Weinstein IB (1987) Growth factors, oncogenes, and multistage carcinogenesis. J Cell Biochem 33:213–224
Wingrove TG, Watt R, Keng P, Macara IG (1988) Stabilization of myc proto-oncogene proteins during Friend murine erythroleukemia cell differentiation. J Biol Chem 263:8918–8924
Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899–6903
Zülch KJ (1979) Histological typing of tumours of the central nervous system. World Health Organization, Geneva
Author information
Authors and Affiliations
Additional information
This work was supported in part by Research Grant from the Hyogo College of Medicine
Rights and permissions
About this article
Cite this article
Shindo, H., Tani, E., Matsumuto, T. et al. Stabilization of c-myc protein in human glioma cells. Acta Neuropathol 86, 345–352 (1993). https://doi.org/10.1007/BF00369446
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00369446